Citation Information :
Aggarwal A, Arora U, Mittal A, Aggarwal A, Singh K, Ray A, Jorwal P, Soneja M, Nischal N, Singh AK, Khanna P, Wig N, Trikha A. Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience. Indian J Crit Care Med 2022; 26 (4):530-532.
Ray A, Jain D, Goel A, Agarwal S, Swaroop S, Das P, et al. Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling. Expert Rev Respir Med 2021;15(10):1367–1375. DOI: 10.1080/17476348.2021.1951708.
Raoof S, Nava S, Carpati C, Hill NS. High-flow, noninvasive ventilation and awake (nonintubation) proning in patients with coronavirus disease 2019 with respiratory failure. Chest 2020;158(5):1992–2002. DOI: 10.1016/j.chest.2020.07.013.
Kodama T, Obinata H, Mori H, Murakami W, Suyama Y, Sasaki H, et al. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems. J Infect Chemother 2021;27(2):336–341. DOI: 10.1016/j.jiac.2020.12.009.
Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMedicine 2020;28. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30314-X/abstract.
Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res 2020;21(1):194. DOI: 10.1186/s12931-020-01455-4.
